Correlation Between TRON and BrightGene Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TRON and BrightGene Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRON and BrightGene Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TRON and BrightGene Bio Medical, you can compare the effects of market volatilities on TRON and BrightGene Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRON with a short position of BrightGene Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRON and BrightGene Bio.

Diversification Opportunities for TRON and BrightGene Bio

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between TRON and BrightGene is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding TRON and BrightGene Bio Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrightGene Bio Medical and TRON is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRON are associated (or correlated) with BrightGene Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrightGene Bio Medical has no effect on the direction of TRON i.e., TRON and BrightGene Bio go up and down completely randomly.

Pair Corralation between TRON and BrightGene Bio

Assuming the 90 days trading horizon TRON is expected to generate 2.12 times more return on investment than BrightGene Bio. However, TRON is 2.12 times more volatile than BrightGene Bio Medical. It trades about 0.09 of its potential returns per unit of risk. BrightGene Bio Medical is currently generating about 0.03 per unit of risk. If you would invest  6.26  in TRON on October 30, 2024 and sell it today you would earn a total of  18.74  from holding TRON or generate 299.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy61.75%
ValuesDaily Returns

TRON  vs.  BrightGene Bio Medical

 Performance 
       Timeline  
TRON 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in TRON are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, TRON exhibited solid returns over the last few months and may actually be approaching a breakup point.
BrightGene Bio Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BrightGene Bio Medical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, BrightGene Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

TRON and BrightGene Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TRON and BrightGene Bio

The main advantage of trading using opposite TRON and BrightGene Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRON position performs unexpectedly, BrightGene Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrightGene Bio will offset losses from the drop in BrightGene Bio's long position.
The idea behind TRON and BrightGene Bio Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities